SUMMARY OF WARRANT (Details) - Warrant [Member] - $ / shares |
3 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Number of Warrants Outstanding, Beginning | 3,243,549 | |
| Weighted Average Exercise Price, Outstanding, Beginning | $ 267.57 | |
| Weighted Average Remaining Life Outstanding | 3 years 5 months 23 days | 2 months 1 day |
| Number of Warrants, Granted | ||
| Weighted Average Exercise Price, Granted | ||
| Number of Warrants, Expired | (3,169,043) | |
| Weighted Average Exercise Price, Expired | $ 273.79 | |
| Number of Warrants, Exercised | ||
| Weighted Average Exercise Price, Exercised | ||
| Number of Warrants Outstanding, Ending | 74,506 | 3,243,549 |
| Weighted Average Exercise Price, Outstanding, Ending | $ 0.84 | $ 267.57 |
| X | ||||||||||
- Definition Number of warrants outstanding, weighted average exercise price, expired No definition available.
|
| X | ||||||||||
- Definition Number of warrants outstanding, weighted average exercise price, expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Share based payment award non option equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|